A detailed history of Sg Americas Securities, LLC transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Sg Americas Securities, LLC holds 25,254 shares of PCRX stock, worth $491,695. This represents 0.0% of its overall portfolio holdings.

Number of Shares
25,254
Previous 12,858 96.41%
Holding current value
$491,695
Previous $368,000 3.26%
% of portfolio
0.0%
Previous 0.0%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 03, 2024

BUY
$11.7 - $28.46 $145,033 - $352,790
12,396 Added 96.41%
25,254 $380,000
Q2 2024

Jul 12, 2024

BUY
$25.5 - $31.51 $235,671 - $291,215
9,242 Added 255.59%
12,858 $368,000
Q1 2024

May 06, 2024

BUY
$27.7 - $35.48 $100,163 - $128,295
3,616 New
3,616 $106,000
Q3 2023

Oct 13, 2023

BUY
$30.68 - $40.09 $183,435 - $239,698
5,979 Added 37.69%
21,843 $670,000
Q2 2023

Jul 10, 2023

BUY
$36.12 - $47.5 $190,135 - $250,040
5,264 Added 49.66%
15,864 $636,000
Q1 2023

Apr 28, 2023

BUY
$35.53 - $43.38 $282,854 - $345,348
7,961 Added 301.67%
10,600 $433,000
Q4 2022

Feb 02, 2023

SELL
$38.19 - $57.45 $248,578 - $373,942
-6,509 Reduced 71.15%
2,639 $102,000
Q3 2022

Oct 31, 2022

SELL
$51.24 - $58.89 $368,056 - $423,006
-7,183 Reduced 43.98%
9,148 $487,000
Q2 2022

Jul 29, 2022

BUY
$51.49 - $81.64 $221,098 - $350,562
4,294 Added 35.67%
16,331 $952,000
Q1 2022

Apr 29, 2022

SELL
$60.03 - $76.49 $925,782 - $1.18 Million
-15,422 Reduced 56.16%
12,037 $919,000
Q4 2021

Feb 07, 2022

BUY
$47.97 - $62.21 $884,806 - $1.15 Million
18,445 Added 204.63%
27,459 $1.65 Million
Q3 2021

Nov 01, 2021

BUY
$54.64 - $61.3 $160,532 - $180,099
2,938 Added 48.35%
9,014 $505,000
Q2 2021

Aug 12, 2021

SELL
$59.18 - $69.99 $703,354 - $831,831
-11,885 Reduced 66.17%
6,076 $369,000
Q1 2021

May 13, 2021

SELL
$59.31 - $78.82 $2.77 Million - $3.68 Million
-46,741 Reduced 72.24%
17,961 $1.26 Million
Q4 2020

Feb 04, 2021

BUY
$50.47 - $66.26 $1.56 Million - $2.05 Million
30,935 Added 91.61%
64,702 $3.87 Million
Q3 2020

Nov 09, 2020

BUY
$51.97 - $63.0 $1.61 Million - $1.95 Million
30,950 Added 1098.69%
33,767 $2.03 Million
Q2 2020

Jul 20, 2020

SELL
$30.8 - $52.47 $183,383 - $312,406
-5,954 Reduced 67.88%
2,817 $148,000
Q1 2020

Apr 30, 2020

BUY
$28.4 - $50.7 $102,580 - $183,128
3,612 Added 70.01%
8,771 $294,000
Q4 2019

Jan 28, 2020

SELL
$36.31 - $46.83 $78,574 - $101,340
-2,164 Reduced 29.55%
5,159 $234,000
Q3 2019

Nov 04, 2019

SELL
$35.66 - $44.99 $2.76 Million - $3.48 Million
-77,420 Reduced 91.36%
7,323 $279,000
Q2 2019

Jul 29, 2019

BUY
$36.57 - $47.97 $2.99 Million - $3.92 Million
81,699 Added 2683.94%
84,743 $3.69 Million
Q1 2019

Apr 29, 2019

BUY
$36.47 - $42.17 $19,693 - $22,771
540 Added 21.57%
3,044 $116,000
Q4 2018

Feb 01, 2019

BUY
$41.31 - $52.16 $103,440 - $130,608
2,504 New
2,504 $108,000
Q4 2017

Jan 24, 2018

SELL
$31.85 - $46.95 $336,304 - $495,745
-10,559 Closed
0 $0
Q3 2017

Nov 07, 2017

BUY
$35.7 - $39.5 $376,956 - $417,080
10,559
10,559 $396,000

Others Institutions Holding PCRX

About Pacira BioSciences, Inc.


  • Ticker PCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,824,200
  • Market Cap $892M
  • Description
  • Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...
More about PCRX
Track This Portfolio

Track Sg Americas Securities, LLC Portfolio

Follow Sg Americas Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.